Longqin Hu received his Bachelor degree in Pharmacy in 1984 and a Master’s degree in Medicinal Chemistry in 1987 from the Second Military Medical University in Shanghai, China. From1988 to 1993, he studied for his Ph.D. degree in Medicinal Chemistry at the University of Kansas under the direction of Professor Michael B. Doughty. After receiving his doctoral degree in Medicinal Chemistry, he worked as an NIH postdoctoral fellow with Professor Roberta F. Colman in Biochemistry at the University of Delaware. Dr. Hu started his academic career in 1996 as an Assistant Professor at the University of Oklahoma. In 1999, he moved to Rutgers University, rose through the ranks, and is currently a Professor and Chair in the Department of Medicinal Chemistry, Ernest Mario School of Pharmacy. He also served as the Director of the Graduate Program in Medicinal Chemistry at Rutgers between 2012 and 2022. He has been a member of the Cancer Institute of New Jersey since 2001. He served as an Associate Editor-in-Chief of Acta Pharmaceutica Sinica B from 2011 to 2019 and has been serving since 2020 as the Editor-in-Chief of Medicinal Chemistry Research (MCR), an academic journal published by Springer Nature. His current research interests are in the general area of synthetic medicinal chemistry and bioorganic chemistry. His research has been funded by grants from National Institutes of Health, American Cancer Society, Department of Defense Medical Research Programs, State of New Jersey Commission of Cancer Research, and Pardee Foundation.